Ziv Sandalon

Title: Ziv Sandalon: Innovator in Gene Therapy

Introduction

Ziv Sandalon is a prominent inventor based in Bellevue, WA (US). He has made significant contributions to the field of gene therapy through his innovative work. With a total of 2 patents, Sandalon is recognized for his advancements in recombinant vector technology.

Latest Patents

Sandalon's latest patents include the development of hybrid adenovirus/adeno-associated virus vectors and methods of use thereof. This invention provides recombinant vectors, including adenovirus/adeno-associated virus (Ad/AAV) vectors and mini-adenovirus (mAd) vectors. Furthermore, the invention encompasses cells containing these vectors, along with methods for making and utilizing the vectors and cells. The compositions and methods of this invention are particularly useful in transferring nucleotide sequences of interest into a cell, especially in gene therapy applications.

Career Highlights

Ziv Sandalon is affiliated with the State University of New York, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential applications in medical therapies and genetic research.

Collaborations

Sandalon has collaborated with notable colleagues, including Patrick Hearing and Wadie F Bahou. These partnerships have contributed to the development and refinement of his innovative technologies.

Conclusion

Ziv Sandalon's contributions to gene therapy through his patented inventions highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical science and therapeutic applications.